|
HNRNPA3P1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.585600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.549990E-02 |
| Normal-vs-Stage2 |
9.675100E-03 |
| Normal-vs-Stage3 |
2.62890000002347E-06 |
| Normal-vs-Stage4 |
3.760600E-04 |
| Stage1-vs-Stage2 |
2.209600E-01 |
| Stage1-vs-Stage3 |
9.641600E-04 |
| Stage1-vs-Stage4 |
4.095800E-02 |
| Stage2-vs-Stage3 |
2.987200E-01 |
| Stage2-vs-Stage4 |
7.022000E-01 |
| Stage3-vs-Stage4 |
4.498400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.270400000006E-05 |
| Normal-vs-AfricanAmerican |
4.754200E-01 |
| Normal-vs-Asian |
7.700800E-01 |
| Caucasian-vs-AfricanAmerican |
6.177700E-03 |
| Caucasian-vs-Asian |
7.440000E-02 |
| AfricanAmerican-vs-Asian |
5.568600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.27810000000117E-05 |
| Normal-vs-Female |
1.285610E-02 |
| Male-vs-Female |
3.187800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.838400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.164600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.80290000000505E-05 |
| Normal-vs-Age(81-100Yrs) |
1.224820E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.901800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.037600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.486500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.319980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.670000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.957600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.867900E-02 |
| Normal-vs-Grade 2 |
1.427690E-02 |
| Normal-vs-Grade 3 |
6.53299999986423E-07 |
| Normal-vs-Grade 4 |
2.141200E-03 |
| Grade 1-vs-Grade 2 |
2.781000E-03 |
| Grade 1-vs-Grade 3 |
3.33109999994807E-06 |
| Grade 1-vs-Grade 4 |
1.356640E-03 |
| Grade 2-vs-Grade 3 |
1.896910E-03 |
| Grade 2-vs-Grade 4 |
1.226160E-01 |
| Grade 3-vs-Grade 4 |
6.246200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.668300E-02 |
| Normal-vs-ccB subtype |
1.72070000026281E-07 |
| ccA subtype-vs-ccB subtype |
6.99300000017722E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63550999999762E-05 |
| Normal-vs-N1 |
1.299190E-01 |
| N0-vs-N1 |
5.485200E-01 |
|
|
